Preparation and Testing of Reagent Water in the Clinical Laboratory - CLSI

Preparation and Testing of Reagent Water in the Clinical Laboratory; Approved Guideline- Fourth Edition C3-A4 Vol 26 #22 (26)
CLSI (Author)

Book Details
* Paperback
* Publisher: NCCLS; 22 edition (2006)
* ISBN-10: 1562386107

Book Description
This document provides guidelines towards reagent water testing requirements in the clinical and research laboratories where reagent-grade water is used.

Download

Handbook of Antimicrobial Therapy

Handbook of Antimicrobial Therapy
Medical Letter (Corporate Author)

Book Details
* Paperback: 475 pages
* Publisher: Medical Letter; 18 edition (April 2008)
* Language: English
* ISBN-10: 0971909385


Book Description
The Medical Letter, Inc. is a nonprofit company founded in 1958 by Arthur Kallet, the co-founder of Consumers Union, and Dr. Harold Aaron, with the goal of providing healthcare professionals with objective, independent analyses of both prescription and over-the-counter drugs. In addition to its newsletters, The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter, the company also publishes handbooks and software on topics such as adverse drug interactions and antimicrobial therapy. It is supported solely by subscription fees and accepts no advertising, grants or donations.

The Medical Letter on Drugs and Therapeutics offers comprehensive drug evaluations of virtually all new drugs and reviews of older drugs when important new information becomes available on their usefulness or adverse effects. Occasionally, The Medical Letter publishes an article on a new non-drug treatment or a diagnostic aid. Treatment Guidelines from The Medical Letter consists of review articles of drug classes for treatment of major indications. A typical issue contains recommendations for first choice and alternative drugs with assessments of the drugs’ effectiveness, safety and cost. The Medical Letter is published every other week and Treatment Guidelines is published once a month. Both are intended to meet the needs of the busy healthcare professional who wants unbiased, reliable and timely information on new drugs and comprehensive reviews of treatments of choice for major indications. Both publications help healthcare professionals make decisions based on the best interests of their patients, rather than the commercial interests of the pharmaceutical industry.

Download